 | | PRD_000825 | | Name: | ATKIDNLD peptide | | Formula: | C37 H63 N10 O14 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000826 | | Name: | SRKIDNLD peptide | | Formula: | C39 H69 N13 O14 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000827 | | Name: | SHKIDNLD peptide | | Formula: | C39 H64 N12 O14 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000828 | | Name: | Trichovirin I-4A | | Formula: | C67 H115 N15 O16 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000829 | | Name: | OS1 peptide | | Formula: | C51 H87 N17 O16 S3 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000833 | | Name: | 5-methyltetrahydrofolate pentaglutamate | | Formula: | C40 H53 N11 O18 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000842 | | Name: | PTA-SFTI INHIBITOR | | Formula: | C66 H106 N20 O18 S2 | | Description: | Bowman-Birk Inhibitor | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000843 | | Name: | (1R,2S,5S)-N-[(2S,3R)-4-amino-1-cyclobutyl-3-hydroxy-4-oxobutan-2-yl]-6,6-dimethyl-3-{3-methyl-N-[(1-methylcyclohexyl)c
arbamoyl]-L-valyl}-3-azabicyclo[3.1.0]hexane-2-carboxamide | | Formula: | C30 H51 N5 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000845 | | Name: | N-[(cyclopentyloxy)carbonyl]-3-methyl-L-valyl-(4R)-4-[(8-bromo-7-methoxy-2-{2-[(2-methylpropanoyl)amino]-1,3-thiazol-4-yl}quinolin-4-yl)oxy]-N-[(1R,2S)-1-carboxy-2-ethenylcyclopropyl]-L-prolinamide | | Formula: | C40 H49 Br N6 O9 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000846 | | Name: | TRYPSIN INHIBITOR 1 | | Formula: | C66 H106 N20 O18 S2 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000849 | | Name: | N-[(cyclopentyloxy)carbonyl]-3-methyl-L-valyl-(4R)-N-[(1R,2S)-1-carboxy-2-ethenylcyclopropyl]-4-[(7-methoxy-2-{2-[(2-methylpropanoyl)amino]-1,3-thiazol-4-yl}quinolin-4-yl)oxy]-L-prolinamide | | Formula: | C40 H50 N6 O9 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000854 | | Name: | DB6 peptide | | Formula: | C57 H77 N13 O11 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000855 | | Name: | DB5 peptide | | Formula: | C49 H74 N15 O10 S | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000857 | | Name: | SAH-p53-8 stapled-peptide | | Formula: | C96 H151 N26 O25 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000870 | | Name: | bisubstrate inhibitor | | Formula: | C23 H30 N6 O18 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000877 | | Name: | (2S)-1-[(2R)-2-(benzylsulfonylamino)-5-guanidino-pentanoyl]-N-[(4-carbamimidoylphenyl)methyl]pyrrolidine-2-carboxamide | | Formula: | C26 H36 N8 O4 S | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000887 | | Name: | (2S)-N-[[2-(aminomethyl)-5-chloranyl-phenyl]methyl]-1-[(2S)-2-[(3-chloranyl-4-methoxy-phenyl)sulfonylamino]-4-[(4-cyanophenyl)methylamino]-4-oxidanylidene-butanoyl]pyrrolidine-2-carboxamide | | Formula: | C32 H34 Cl2 N6 O6 S | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000892 | | Name: | METHYL (2R)-1-[(6S,9S,12S,13S,17S,20S,23R)-9-(3-AMINO-3-OXOPROPYL)-12,23-DIBENZYL-13-HYDROXY-2,2,8,20,22-PENTAMETHYL-17-(2-METHYLPROPYL)-4,7,10,15,18,21,24-HEPTAOXO-6-(PROPAN-2-YL)-3-OXA-5,8,11,16,19,22-HEXAAZATETRACOSAN-24-YL]PYRROLIDINE-2-CARBOXYLATE | | Formula: | C52 H78 N8 O12 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000893 | | Name: | METHYL (2S)-1-[(2R,5S,8S,12S,13S)-2,13-DIBENZYL-12-HYDROXY-3,5-DIMETHYL-15-(3-[METHYL(METHYLSULFONYL)AMINO]-5-{[(1R)-1-PHENYLETHYL]CARBAMOYL}PHENYL)-8-(2-METHYLPROPYL)-4,7,10,15-TETRAOXO-3,6,9,14-TETRAAZAPENTADECAN-1-OYL]PYRROLIDINE-2-CARBOXYLATE | | Formula: | C54 H69 N7 O11 S | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000901 | | Name: | thiomuracin A derivative | | Formula: | C53 H54 N13 O9 S6 | | Definition date: | 2012-12-26 | | Last modified: | 2023-11-03 |
|
 | | PRD_000958 | | Name: | tert-butyl {(2S)-1-[(1R,2S,5S)-2-{[(2S,3R)-4-amino-1-cyclopropyl-3-hydroxy-4-oxobutan-2-yl]carbamoyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hex-3-yl]-3,3-dimethyl-1-oxobutan-2-yl}carbamate | | Formula: | C26 H44 N4 O6 | | Definition date: | 2012-12-26 | | Last modified: | 2012-12-26 |
|
 | | PRD_000898 | | Name: | METHYL (2S)-1-[(2R,5S,8S,12S,13S,16S,19S,22S)-16-(3-AMINO-3-OXOPROPYL)-2,13-DIBENZYL-12,22-DIHYDROXY-3,5,17-TRIMETHYL-8-(2-METHYLPROPYL)-4,7,10,15,18,21-HEXAOXO-19-(PROPAN-2-YL)-3,6,9,14,17,20-HEXAAZATRICOSAN-1-OYL]PYRROLIDINE-2-CARBOXYLATE (NON-PREFERRED NAME) | | Formula: | C50 H74 N8 O12 | | Definition date: | 2013-01-16 | | Last modified: | 2013-06-03 |
|
 | | PRD_000899 | | Name: | METHYL (2S)-1-[(2R,5S,8S,12S,13S)-2,13-DIBENZYL-12-HYDROXY-3,5-DIMETHYL-8-(2-METHYLPROPYL)-15-(3-[(METHYLSULFONYL)AMINO]-5-{[(1R)-1-PHENYLETHYL]CARBAMOYL}PHENYL)-4,7,10,15-TETRAOXO-3,6,9,14-TETRAAZAPENTADECAN-1-OYL]PYRROLIDINE-2-CARBOXYLATE | | Formula: | C53 H67 N7 O11 S | | Definition date: | 2013-01-16 | | Last modified: | 2013-06-03 |
|
 | | PRD_000908 | | Name: | N-(3-carboxypropanoyl)-L-valyl-N-[(1S)-2-phenyl-1-phosphonoethyl]-L-prolinamide | | Formula: | C22 H32 N3 O8 P | | Definition date: | 2013-01-23 | | Last modified: | 2013-01-23 |
|
 | | PRD_000979 | | Name: | N3Phe-Leu-Leu-Phe(4-NH2CH2)-methyl vinyl sulfone, bound form | | Formula: | C33 H49 N7 O5 S | | Definition date: | 2013-01-30 | | Last modified: | 2013-01-30 |
|
